# ACTH in Progressive Forms of MS

> **NCT01950234** · PHASE2 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 59 (actual)

## Conditions studied

- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Progressive Relapsing Multiple Sclerosis

## Interventions

- **DRUG:** ACTH
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01950234
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04-17
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** The funding source discontinued financial support for the study.
- **Last updated:** 2025-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01950234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01950234, "ACTH in Progressive Forms of MS". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01950234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*